Transforming growth factor-beta 3 (TGF-β3), plays an essential role in these processes, and is known to be involved in the pathogenesis of hypertensive disorders in pregnancy 36-39 and some forms of OFCs 36,40. This evidence concerns the gene TGFB3 and hypertensive disorder.